Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
by
Weitz, Jeffrey I
, Albers, Gregory W
, Spiro, Theodore E
, Hiatt, William R
, Barnathan, Elliot S
, Maynard, Gregory A
, Suh, Eunyoung
, Elliott, C. Gregory
, Steg, P. Gabriel
, Halperin, Jonathan L
, Raskob, Gary E
, Spyropoulos, Alex C
, Ageno, Walter
in
Aftercare
/ Aged
/ Anticoagulants
/ Bleeding
/ Collaboration
/ Double-Blind Method
/ Drug Administration Schedule
/ Embolisms
/ Factor Xa Inhibitors - administration & dosage
/ Factor Xa Inhibitors - adverse effects
/ Factor Xa Inhibitors - therapeutic use
/ Fees & charges
/ Female
/ Health risk assessment
/ Heart failure
/ Hemorrhage - chemically induced
/ Hospitalization
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Male
/ Middle Aged
/ Motivation
/ Patient Discharge
/ Patients
/ R&D
/ Renal insufficiency
/ Research & development
/ Rivaroxaban - administration & dosage
/ Rivaroxaban - adverse effects
/ Rivaroxaban - therapeutic use
/ Stroke
/ Thromboembolism
/ Thrombosis
/ Treatment Outcome
/ Veins & arteries
/ Venous Thromboembolism - epidemiology
/ Venous Thromboembolism - mortality
/ Venous Thromboembolism - prevention & control
/ Venous Thrombosis - prevention & control
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
by
Weitz, Jeffrey I
, Albers, Gregory W
, Spiro, Theodore E
, Hiatt, William R
, Barnathan, Elliot S
, Maynard, Gregory A
, Suh, Eunyoung
, Elliott, C. Gregory
, Steg, P. Gabriel
, Halperin, Jonathan L
, Raskob, Gary E
, Spyropoulos, Alex C
, Ageno, Walter
in
Aftercare
/ Aged
/ Anticoagulants
/ Bleeding
/ Collaboration
/ Double-Blind Method
/ Drug Administration Schedule
/ Embolisms
/ Factor Xa Inhibitors - administration & dosage
/ Factor Xa Inhibitors - adverse effects
/ Factor Xa Inhibitors - therapeutic use
/ Fees & charges
/ Female
/ Health risk assessment
/ Heart failure
/ Hemorrhage - chemically induced
/ Hospitalization
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Male
/ Middle Aged
/ Motivation
/ Patient Discharge
/ Patients
/ R&D
/ Renal insufficiency
/ Research & development
/ Rivaroxaban - administration & dosage
/ Rivaroxaban - adverse effects
/ Rivaroxaban - therapeutic use
/ Stroke
/ Thromboembolism
/ Thrombosis
/ Treatment Outcome
/ Veins & arteries
/ Venous Thromboembolism - epidemiology
/ Venous Thromboembolism - mortality
/ Venous Thromboembolism - prevention & control
/ Venous Thrombosis - prevention & control
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
by
Weitz, Jeffrey I
, Albers, Gregory W
, Spiro, Theodore E
, Hiatt, William R
, Barnathan, Elliot S
, Maynard, Gregory A
, Suh, Eunyoung
, Elliott, C. Gregory
, Steg, P. Gabriel
, Halperin, Jonathan L
, Raskob, Gary E
, Spyropoulos, Alex C
, Ageno, Walter
in
Aftercare
/ Aged
/ Anticoagulants
/ Bleeding
/ Collaboration
/ Double-Blind Method
/ Drug Administration Schedule
/ Embolisms
/ Factor Xa Inhibitors - administration & dosage
/ Factor Xa Inhibitors - adverse effects
/ Factor Xa Inhibitors - therapeutic use
/ Fees & charges
/ Female
/ Health risk assessment
/ Heart failure
/ Hemorrhage - chemically induced
/ Hospitalization
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Male
/ Middle Aged
/ Motivation
/ Patient Discharge
/ Patients
/ R&D
/ Renal insufficiency
/ Research & development
/ Rivaroxaban - administration & dosage
/ Rivaroxaban - adverse effects
/ Rivaroxaban - therapeutic use
/ Stroke
/ Thromboembolism
/ Thrombosis
/ Treatment Outcome
/ Veins & arteries
/ Venous Thromboembolism - epidemiology
/ Venous Thromboembolism - mortality
/ Venous Thromboembolism - prevention & control
/ Venous Thrombosis - prevention & control
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Journal Article
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Patients discharged from the hospital carry an increased risk of venous thromboembolism after discharge. A randomized trial of rivaroxaban for 6 weeks after hospital discharge had no significant effect on the risk of venous thromboembolism as compared with placebo.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Bleeding
/ Drug Administration Schedule
/ Factor Xa Inhibitors - administration & dosage
/ Factor Xa Inhibitors - adverse effects
/ Factor Xa Inhibitors - therapeutic use
/ Female
/ Hemorrhage - chemically induced
/ Humans
/ Male
/ Patients
/ R&D
/ Rivaroxaban - administration & dosage
/ Rivaroxaban - adverse effects
/ Rivaroxaban - therapeutic use
/ Stroke
/ Venous Thromboembolism - epidemiology
/ Venous Thromboembolism - mortality
This website uses cookies to ensure you get the best experience on our website.